Dammarenediol II
CAS No. 14351-29-2
Dammarenediol II ( —— )
产品货号. M30869 CAS No. 14351-29-2
Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥4066 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Dammarenediol II
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.
-
产品描述Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy, it can inhibit vascular endothelial growth factor (VEGF)-induced intracellular reactive oxygen species generation and stress fiber formation and vascular endothelial-cadherin disruption. The medicinally important dammarenediol II can be ectopically produced in tobacco, and the production of dammarenediol-II in tobacco plants allows them to adopt a viral defense system.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number14351-29-2
-
分子量444.7
-
分子式C30H52O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (112.43 mM)
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Epitinib succinate
琥珀酸依替尼是一种口服活性选择性表皮生长因子受体酪氨酸激酶抑制剂 (EGFR-TKI),旨在实现最佳的脑渗透。琥珀酸依替尼可用于癌症研究。
-
(S)-Desmethyl-NNC112
(S)-Desmethyl-NNC112 ((+)-Desmethyl-NNC112) is a selective PET radioligand that binds to D-dopamine receptors.
-
Methylsyringin
Methylsyringin 在 LPS 刺激的 RAW264.7 细胞中显示出抗炎活性。
021-51111890
购物车()
sales@molnova.cn

